Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

AI and Radar Technologies Could Help Diabetics Manage Their Disease

By University of Waterloo | June 28, 2018

People with diabetes could be able to monitor their blood sugar without drawing blood using a system now being developed at the University of Waterloo.

In a recent study, researchers combined radar and artificial intelligence (AI) technologies to detect changes in glucose levels without the need for painful finger pricks several times a day.

“We want to sense blood inside the body without actually having to sample any fluid,” said George Shaker, an engineering professor who leads a large team working on the concept. “Our hope is this can be realized as a smartwatch to monitor glucose continuously.”

The research involves collaboration with Google and German hardware company Infineon, which jointly developed a small radar device and sought input from select teams around the world on potential applications.

The system at Waterloo uses the radar device to send high-frequency radio waves into liquids containing various levels of glucose and receive radio waves that are reflected back to it.

Information on the reflected waves is then converted into digital data for analysis by machine-learning AI algorithms developed by the researchers.

The software is capable of detecting glucose changes based on more than 500 wave features or characteristics, including how long it takes for them to bounce back to the device.

Initial tests with volunteers at the Research Institute for Aging in Waterloo achieved results that were 85 per cent as accurate as traditional, invasive blood analysis. “The correlation was actually amazing,” said Shaker. “We have shown it is possible to use radar to look into the blood to detect changes.”

Next steps include refining the system to precisely quantify glucose levels and obtain results through the skin, which complicates the process.

Researchers are also working with Infineon to shrink the radar device so that it is both low-cost and low-power.

The data analyzed by AI algorithms is now sent wirelessly to computers, but the ultimate aim is self-contained technology similar to the smartwatches that monitor heart rate.

“I’m hoping we’ll see a wearable device on the market within the next five years,” said Shaker. “There are challenges, but the research has been going at a really good rate.”

Related Articles Read More >

OpenAI unveils BioBasicsBench, a benchmark to gauge how well AI agents read raw experimental data across 100 routine wet-lab tasks.
Kosmos world model diagram: three colored paths of connected nodes trace three discoveries built from data-analysis agent steps, literature-review agent steps and established findings.
Edison’s Kosmos AI scientist moves into Pfizer R&D; Edison details the math behind its $99 million-per-program estimate
Max Jaderberg, president of Isomorphic Labs, in a tan jacket and white shirt against a pale blue backdrop
Isomorphic Labs president says all drugs will be AI-designed as first trials near a year-end target
Headshot of Michael Schnall-Levin, chief technology officer of 10x Genomics, against a light gray background.
10x Genomics CTO expects AI to leave some of biomedical R&D ‘painfully slow’ while other parts are ‘massively accelerated’
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2026 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE